Skip to main content
Equibles
NOVT logo

NOVT · Novanta Inc · Investor Relations

Track NOVT — free

Use NOVT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NOVT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$144.69 +2.50 (+1.76%)
S&P 400 member Russell 2000 member Rebalance outlook locked
Market Cap
$5.44B
Shares
37.82M
Volume · Oct 1 99.35K Avg daily vol (3M) 417.63K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-07-27 Novanta Completes Acquisition of Riverpoint Medical
2026-07-14 Novanta Inc. Announces Schedule of Second Quarter 2026 Earnings Release and Conference Call
2026-06-22 Novanta to Present at the CJS Securities 26th Annual New Ideas Summer Conference on Thursday, July 9, 2026
2026-06-09 Novanta Inc. Announces $300 Million Private Placement
2026-06-09 Novanta Inc. Announces Acquisition of Riverpoint Medical
2026-05-15 Novanta to Present at Jefferies Global Healthcare Conference on Thursday, June 4, 2026
2026-05-15 Novanta to Present at Baird 2026 Global Consumer, Technology & Services Conference on Wednesday, June 3, 2026
2026-05-13 Novanta to Present at the William Blair 46th Annual Growth Stock Conference on Tuesday, June 2, 2026
2026-05-11 Novanta Announces Financial Results for the First Quarter 2026
2026-04-14 Novanta Inc. Announces Schedule of First Quarter 2026 Earnings Release and Conference Call
2026-03-16 Novanta Joins NVIDIA Halos AI Systems Inspection Lab
2026-02-23 Novanta Announces Financial Results for the Fourth Quarter and Full Year 2025
2026-01-22 Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, February 24, 2026

Past events

Date Event Type
2026-08-06 Novanta Inc. Announces Schedule of Second Quarter 2026 Earnings Release and Conference Call Earnings call
2026-06-09 Announcement of Riverpoint Medical acquisition Event
2026-06-04 Jefferies Global Healthcare Conference Conference
2026-06-03 Baird 2026 Global Consumer, Technology & Services Conference Conference
2026-06-02 William Blair 46th Annual Growth Stock Conference Conference
2026-05-12 Novanta, Inc. 2026 Q1 Earnings Call Earnings call
2026-02-24 Novanta, Inc. 2025 Q4 Earnings Call Earnings call
2026-01-14 J.P. Morgan 44th Annual Healthcare Conference Conference
2026-01-14 CJS Securities 26th Annual New Ideas for the New Year Investor Conference Conference
2025-11-18 Jefferies Global Healthcare Conference Conference
2025-11-11 Baird 2025 Global Industrial Conference Conference
2025-11-04 Novanta, Inc. 2025 Q3 Earnings Call Earnings call
2025-10-28 Jefferies Global Healthcare Conference Conference
2025-10-27 Novanta Hosts ISO event for Humanoid Robot Safety Standards Event
2025-09-09 Baird 2025 Global Healthcare Conference Conference
2025-08-05 Novanta, Inc. 2025 Q2 Earnings Call Earnings call
2025-07-10 CJS Securities 25th Annual New Ideas Summer Conference Conference
2025-06-04 Baird 2025 Global Consumer, Technology & Services Conference Conference
2025-06-03 William Blair 45th Annual Growth Stock Conference Conference
2025-05-06 Novanta, Inc. 2025 Q1 Earnings Call Earnings call
2025-02-25 Novanta, Inc. 2024 Q4 Earnings Call Earnings call
2025-01-14 CJS 25th Annual New Ideas for the New Year Conference Conference
2025-01-13 J.P. Morgan 43rd Annual Healthcare Conference Conference
2024-11-13 Baird 2024 Global Industrial Conference Conference
2024-11-05 Novanta, Inc. 2024 Q3 Earnings Call Earnings call

Source: https://investors.novanta.com/overview/default.aspx

Key facts CIK 1076930 CUSIP 67000B104 13F (30d) 11 filings 10 filers Visit website Investor relations